<DOC>
	<DOCNO>NCT01488747</DOCNO>
	<brief_summary>The primary objective investigation determine relative percentage rate incorporation eicosapentaenoic acid ( EPA ) , docosahexaenoic acid ( DHA ) total omega-3 ( n-3 ) fatty acid ingestion 4 emulsify flavor triglyceride fish oil supplement versus encapsulate triglyceride define plasma lipid pool . The primary endpoint evaluate include fatty acid composition plasma lipid consumption single dose emulsify triglyceride base fish oil triglyceride similar n-3 composition capsule form . The investigator measure change plasma phospholipid , chylomicron fatty acid .</brief_summary>
	<brief_title>Bioavailability Fish Oils : Emulsified Versus Capsular Triglyceride</brief_title>
	<detailed_description />
	<criteria>1 . Healthy adult age 18 60 . 2 . Body mass index 22 32 kg/m2 . 3 . Medical history ( interview ) demonstrate good health . 4 . Nonsmoker . 5 . Consumption typical American diet unusual dietary habit . 6 . Willingness comply study protocol . 7 . Low report n3 intake ( &lt; 100 mg/d ) Omega3 Checklist 1 . Any active , uncontrolled medical problem . 2 . Consumption essential fatty acid supplement within past 6 month . 3 . Use lipid lower drug . 4 . Fish consumption great 1 fish meal per week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Omega-3 fatty acid</keyword>
	<keyword>Phospholipid fatty acid</keyword>
	<keyword>chymlomicron fatty acid</keyword>
	<keyword>Bioavailability fo fish oil supplement healthy adult</keyword>
</DOC>